Wednesday, 3 Dec 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    Mohammed R. Mhawish Awarded 2025 Neal Conan Prize for Excellence in Journalism
    02/12/2025
    TraceLink Announces 2025 Corporate Grant Recipients Driving Global Community Impact
    TraceLink Announces 2025 Corporate Grant Recipients Driving Global Community Impact
    02/12/2025
    CQ Medical Expands Radiation Therapy Portfolio With Bionix Business Unit Acquisition
    CQ Medical Expands Radiation Therapy Portfolio With Bionix Business Unit Acquisition
    02/12/2025
    American Power Systems unveils high-output dual alternator solution for Nissan Patrol
    American Power Systems unveils high-output dual alternator solution for Nissan Patrol
    02/12/2025
    CQ Medical Expands Radiation Therapy Portfolio With Bionix Business Unit Acquisition
    Xinhua Silk Road: Hainan to host talent-exchange conference in December
    01/12/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • global
  • Business
  •  and
  • announced
  •  the
  • today
  • company
  •  for
  • Tech
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Business

Russell Reynolds Associates Names Dr. Tomas Chamorro-Premuzic as Firm’s First Chief Science Officer

PRNW Agency
Last updated: 10/11/2025 11:31 PM
PRNW Agency
Share
3 Min Read
Russell Reynolds Associates Names Dr. Tomas Chamorro-Premuzic as Firm’s First Chief Science Officer
SHARE
Russell Reynolds Associates Names Dr. Tomas Chamorro-Premuzic as Firm’s First Chief Science Officer

Strategic hire deepens firm’s global leadership advisory capabilities in advanced data, science, and innovation

- Advertisement -

NEW YORK, Nov. 10, 2025 /PRNewswire/ — Russell Reynolds Associates (RRA), the leading global leadership advisory firm, is pleased to welcome Dr. Tomas Chamorro-Premuzic as its first Chief Science Officer. In this new global role, Dr. Chamorro-Premuzic will lead RRA’s research and development (R&D) and innovation initiatives, driving the firm’s data strategy and the development of proprietary insights to further enhance RRA’s advisory capabilities.

- Advertisement -

As advanced technology platforms and artificial intelligence continue to transform leadership advisory services, this appointment reinforces RRA’s commitment to leveraging advanced analytics to deepen client impact worldwide. Dr. Chamorro-Premuzic’s role represents a critical new capability, focusing on the content and process aspects of the firm’s data strategy, enhancing the technological advancements led by Chief Technology and Data Officer Harpreet Khurana. In this capacity, Dr. Chamorro-Premuzic will oversee the Center for Leadership Insight, which explores the forces shaping modern leadership, including economic and geopolitical uncertainty, generative AI, board culture, and the development of next-generation leaders. 

- Advertisement -

“The integration of cutting-edge science and data-driven insights is paramount to delivering unparalleled value to our clients,” said Constantine Alexandrakis, CEO of Russell Reynolds Associates. “Dr. Chamorro-Premuzic is an internationally recognized leader whose profound expertise will be instrumental in shaping our future impact. His appointment as our first Chief Science Officer marks a critical and bold step in advancing the firm’s capabilities and ensuring we remain at the forefront of leadership advisory.”

- Advertisement -

Dr. Chamorro-Premuzic joins RRA with a distinguished professional and academic background, recognized as a leading, global authority in people analytics, talent management, and leadership development. He previously served as Chief Innovation Officer at ManpowerGroup, in addition to Chief Executive Officer of Hogan Assessment Systems, where he co-created RRA’s proprietary Leadership Span model. Dr. Chamorro-Premuzic is also a co-founder of DeeperSignals, an end-to-end soft-skills intelligence platform, and MyTrudy, a psychometric assessment platform for job seekers. Beyond his corporate leadership, Dr. Chamorro-Premuzic is a Professor of Business Psychology at University College London and Columbia University and is a prolific author of 15 books and over 250 scientific papers.

- Advertisement -

About Russell Reynolds Associates
Russell Reynolds Associates is a global leadership advisory firm that helps organizations build adaptive leadership capabilities and unlock their potential for growth. We use our global network and deep insights to provide executive search, leadership assessment, and development advisory services across all industries and geographies.

- Advertisement -


Media Contact


Russell Reynolds Associates
Amy Scissons
Chief Marketing and Communications Officer
amy.scissons@russellreynolds.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/1502546/Russell_Reynolds_Associates_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/russell-reynolds-associates-names-dr-tomas-chamorro-premuzic-as-firms-first-chief-science-officer-302609145.html

- Advertisement -
Coventry and Alan Buerger Move to Dismiss Abacus Lawsuit
Addverb reinvents its factory automation development with Siemens Xcelerator
Building Smarter Equipment: SANY Is Accelerating Intelligent Transformation
Radware Schedules Conference Call for Its Second Quarter 2025 Earnings
YPO Elects Debby Carreau 2025-2026 Global Chairman
TAGGED: dradvancedadvisoryassociatescapabilitieschamorro-premuzicchamorropremuzicchiefdatadeepensdevelopmentfirmfirmsfirstglobalhireInnovationleadershipleadingnamesnewsnovofficerpleasedreynoldsrolerrarrasrussellsciencestrategicstrategyTechnologytomaswillyork
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

AVer Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Medical-Grade PTZ Cameras
Entertainment

AVer Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Medical-Grade PTZ Cameras

24/07/2025
New Ameriprise Research: Parents Balance Retirement and Supporting Adult Children Financially
Business

New Ameriprise Research: Parents Balance Retirement and Supporting Adult Children Financially

26/09/2025
Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+
Health

Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+

22/07/2025
Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025
Health

Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025

30/10/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?